Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
about
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsImmune Modulation in Hematologic MalignanciesCatching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and ChangesMacrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.Haematological malignancies: at the forefront of immunotherapeutic innovation.The role of the tumor microenvironment in HIV-associated lymphomasTargeting the tumor niche to treat cancer.T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis.Current status of prognostication in classical Hodgkin lymphoma.The role of T cells in the microenvironment of Hodgkin lymphoma.The emerging role of immune checkpoint inhibition in malignant lymphoma.Current and future immunotherapeutic approaches in Hodgkin lymphoma.Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical resultsThe impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor.PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma.Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas.Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma<sup/>.The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.CXCR5 and ICOS expression identifies a CD8 T-cell subset with T features in Hodgkin lymphomas
P2860
Q26745842-43C6A114-3307-4C5D-9B35-C85A218889ABQ26796307-232AB292-27C9-429E-9638-862317298BD7Q28076071-16A2C0B4-3495-458A-9B7F-DF8B0E26AF76Q28087370-AB1AE431-D417-4CF2-9122-96B8AE52FF4AQ35610687-7872729F-2B60-449E-BCB2-C0350F0C60FCQ35880618-30ADA7D8-7EDE-46A7-B19D-B58538868F7DQ35945221-F79087C6-4B1D-4CF2-95E5-2ACC7EBE3E67Q36207348-53E4B01C-6ECF-4B88-B8B0-02E11D713CFDQ37390723-FB3D2A13-61A0-4E6A-9B9D-9A315C90414DQ37665549-15C9434D-894C-463F-8BA7-4AB59BED5E49Q38185063-EABFE7A6-8BD3-4C71-ADCC-6D289B0F5231Q38576547-DDDE79D0-359C-4D34-9C85-B2206C53887CQ38791036-A4A992B3-BBCE-4961-AA63-6B0EF89774C2Q38848990-A5210A2C-DDD5-407D-8D86-E67D5A6F342CQ38920096-08390F11-EE8B-4B42-ADFF-1657B4F96BC6Q38983067-F66ACF30-83E6-41B7-939E-650DA8899768Q39208496-E9BFA39F-F854-4589-875D-2B34174A599DQ39376074-79568CB3-5206-4155-AA98-FB7870F6EAB6Q39423479-D3D563E8-2687-43A6-8D13-E7722329DE7FQ39937262-3D695961-6B72-42F6-9827-EEB1A9AADA61Q40766253-3A179D86-B9FF-4582-9108-36842E30BFC9Q40853718-3393291C-9034-4B6A-B9B2-98391BAC80BCQ42205109-B7B748B1-82DD-4437-AF14-FB19A6475B80Q43522763-E7686E3B-42AD-40BD-85F3-35E080E0B07CQ44792403-B3EBB4F4-E1A5-4B76-8A13-4C6F10626496Q47125417-E1A9F831-10FD-4825-A289-58A845D46256Q47424027-C439FE85-4E49-42CF-A7B1-F354489596C8Q49028986-962BD1B2-BCEC-4E58-8417-CCCA1907082FQ50056734-CC50CB79-FD9D-4544-9658-CDB1F50956DDQ52839835-C8FCB135-B250-40E9-ADA4-D75EA86D92B9Q53011053-1643DCC2-618D-4F30-8C5D-99E62F963324Q58797081-F7BC6070-D8F5-4176-BAF9-431CC7DC9F05
P2860
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@en
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@nl
type
label
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@en
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@nl
prefLabel
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@en
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
@nl
P2093
P2860
P1433
P1476
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
@en
P2093
Abigail Lee
Andrew Clear
Andrew Owen
Andrew Wilson
Janet Matthews
John G Gribben
Maria Calaminici
Sameena Iqbal
P2860
P304
P356
10.1182/BLOOD-2013-06-508044
P407
P50
P577
2013-09-04T00:00:00Z